Acute Lymphoblastic Leukemia, Pediatric Recruiting Phase 3 Trials for Duloxetine (DB00476)

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs